advertisement

---

Shang L 10

Showing records 1 to 10 | Display all abstracts from Shang L

105752 Correlation between novel compound heterozygous ADAMTSL4 variants and primary phenotypes of ectopia lentis et pupillae
Zhao J
Experimental Eye Research 2022; 224: 109243

---

106836 Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases
Zhang Q; Hu XM
International journal of biological sciences 2023; 19: 658-674

---

105752 Correlation between novel compound heterozygous ADAMTSL4 variants and primary phenotypes of ectopia lentis et pupillae
Zhou Y
Experimental Eye Research 2022; 224: 109243

---

106836 Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases
Zhao WJ
International journal of biological sciences 2023; 19: 658-674

---

105752 Correlation between novel compound heterozygous ADAMTSL4 variants and primary phenotypes of ectopia lentis et pupillae
Zhang J
Experimental Eye Research 2022; 224: 109243

---

106836 Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases
Ban XX
International journal of biological sciences 2023; 19: 658-674

---

105752 Correlation between novel compound heterozygous ADAMTSL4 variants and primary phenotypes of ectopia lentis et pupillae
Zhang K; Shang L
Experimental Eye Research 2022; 224: 109243

---

106836 Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases
Li Y
International journal of biological sciences 2023; 19: 658-674

---

105752 Correlation between novel compound heterozygous ADAMTSL4 variants and primary phenotypes of ectopia lentis et pupillae
Li J
Experimental Eye Research 2022; 224: 109243

---

106836 Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases
Huang YX; Wan H; He Y; Liao LS; Liao LS; Shang L; Jiang B; Qing GP; Xiong K
International journal of biological sciences 2023; 19: 658-674

---